16 September, 2024AAVantgarde announces first patient dosed with AAVB-081 in FIH Phase 1/2 LUCE-1 study for retinitis pigmentosa related to USH1B
12 September, 2024F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US
12 September, 2024Novameat Raises €17.4M Oversubscribed Series A Round Led by Sofinnova Partners and Forbion